In vivo and in vitro reconstitution of unique key steps in cystobactamid antibiotic biosynthesis
The biosynthetic pathway leading to the production of cystobactamids, a group of myxobacteria-derived topoisomerase inhibitors with potent anti-Gram-negative activity, remains unclear. Here, the authors report in vivo and in vitro evidence for unique steps in cystobactamid biosynthesis.
Guardado en:
Autores principales: | Sebastian Groß, Bastien Schnell, Patrick A. Haack, David Auerbach, Rolf Müller |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0b7437a9990648c78f101efed6acc7c3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Author Correction: In vivo and in vitro reconstitution of unique key steps in cystobactamid antibiotic biosynthesis
por: Sebastian Groß, et al.
Publicado: (2021) -
Dissection of goadsporin biosynthesis by in vitro reconstitution leading to designer analogues expressed in vivo
por: Taro Ozaki, et al.
Publicado: (2017) -
Evolutionary conservation and in vitro reconstitution of microsporidian iron–sulfur cluster biosynthesis
por: Sven-A. Freibert, et al.
Publicado: (2017) -
Targeting Bacterial Gyrase with Cystobactamid, Fluoroquinolone, and Aminocoumarin Antibiotics Induces Distinct Molecular Signatures in Pseudomonas aeruginosa
por: Raimo Franke, et al.
Publicado: (2021) -
Elucidation of the biosynthesis of carnosic acid and its reconstitution in yeast
por: Ulschan Scheler, et al.
Publicado: (2016)